Price Chart

Profile

Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.
URL https://www.vaxcyte.com
Investor Relations URL https://investors.vaxcyte.com/
HQ State/Province California
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Blend
Next Earnings Release May. 08, 2024 (est.)
Last Earnings Release Feb. 27, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.
URL https://www.vaxcyte.com
Investor Relations URL https://investors.vaxcyte.com/
HQ State/Province California
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Blend
Next Earnings Release May. 08, 2024 (est.)
Last Earnings Release Feb. 27, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A